Seaquist, E. R., Phillips, L. S., Ghosh, A., Baker, C., Bergenstal, R. M., Crandall, J. P., Goland, R. S., Gramzinski, M. R., Hox, S. H., Hsia, D. S., Johnson, M. L., Lachin, J. M., Raskin, P., Valencia, W. M., Waltje, A. H., & Younes, N. (2024). Glycemia reduction in type 2 diabetes—Hypoglycemia outcomes: A randomized clinical trial. PLOS ONE, 19(11), e0309907. https://doi.org/10.1371/journal.pone.0309907

Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024). Metformin as a Potential Prevention Strategy for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias. Journal of Alzheimer’s Disease, 101(s1), S345–S356. https://doi.org/10.3233/jad-240495

Patel, M., Battarbee, A. N., Refuerzo, J. S., Zork, N., Eichelberger, K., Ramos, G. A., Olson, G., Durnwald, C., Landon, M. B., Aagaard, K. M., Wallace, K., Scifres, C., Rosen, T., Mulla, W., Valent, A., Longo, S., & Boggess, K. A. (2024). Association Between Metformin Use in Early Gestational or Type 2 Diabetes in Pregnancy and Preterm Preeclampsia. Obstetrics & Gynecology, 144(5), 733–739. https://doi.org/10.1097/aog.0000000000005720

Venkatesh, K. K., MacPherson, C., Clifton, R. G., Powe, C. E., Bartholomew, A., Gregory, D., Trinh, A., McAlearney, A. S., Fiechtner, L. G., Catalano, P., Rice, D., Cross, S., Kutay, H., Gabbe, S., Grobman, W. A., Costantine, M. M., Battarbee, A. N., Boggess, K., Katukuri, V., … Landon, M. B. (2024). Comparative effectiveness trial of metformin versus insulin for the treatment of gestational diabetes in the USA: clinical trial protocol for the multicentre DECIDE study. BMJ Open, 14(9), e091176. https://doi.org/10.1136/bmjopen-2024-091176

Khera, R., Aminorroaya, A., Dhingra, L. S., Thangaraj, P. M., Pedroso Camargos, A., Bu, F., Ding, X., Nishimura, A., Anand, T. V., Arshad, F., Blacketer, C., Chai, Y., Chattopadhyay, S., Cook, M., Dorr, D. A., Duarte-Salles, T., DuVall, S. L., Falconer, T., French, T. E., … Suchard, M. A. (2024). Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes. Journal of the American College of Cardiology, 84(10), 904–917. https://doi.org/10.1016/j.jacc.2024.05.069

Shahidehpour, A., Rashid, M., Askari, M. R., Ahmadasas, M., Abdel-Latif, M., Fritschi, C., Quinn, L., Reutrakul, S., Bronas, U. G., & Cinar, A. (2024). Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease. The AAPS Journal, 26(5). https://doi.org/10.1208/s12248-024-00962-2

Boggess, K. A., Valint, A., Refuerzo, J. S., Zork, N., Battarbee, A. N., Eichelberger, K., Ramos, G. A., Olson, G., Durnwald, C., Landon, M. B., Aagaard, K. M., Wallace, K., Scifres, C., Rosen, T., Mulla, W., Valent, A., Longo, S., Young, L., Marquis, M. A., … Berry, D. (2023). Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy. JAMA, 330(22), 2182. https://doi.org/10.1001/jama.2023.22949

Jacofsky, D. J., Springer, B. D., Mont, M. A., Ushakumari, D. S., & Sladen, R. N. (2024). The Impact of Glucagon-Like Peptide-1 Agonists on Hip and Knee Arthroplasty and Perioperative Considerations. The Journal of Arthroplasty, 39(6), 1455–1458. https://doi.org/10.1016/j.arth.2023.12.002

Meister, J., Bone, D. B. J., Knudsen, J. R., Barella, L. F., Velenosi, T. J., Akhmedov, D., Lee, R. J., Cohen, A. H., Gavrilova, O., Cui, Y., Karsenty, G., Chen, M., Weinstein, L. S., Kleinert, M., Berdeaux, R., Jensen, T. E., Richter, E. A., & Wess, J. (2022). Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nature Communications, 13(1). https://doi.org/10.1038/s41467-021-27540-w